Submitted by Anonymous (not verified) on 2 December 2024 - 16:33
Human medicines European public assessment report (EPAR): Eribulin Baxter, eribulin, Date of authorisation: 27/06/2024, Revision: 1, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Eribulin Baxter, eribulin, Date of authorisation: 27/06/2024, Revision: 1, Status: Authorised